Table 1 Baseline characteristics of study patients
Upper GI treatment | Lower GI treatment | Total | |
|---|---|---|---|
HBT patients (number) | 171 | 74 | 245 |
Mean age (mean ± S.D.) | 74.1 ± 8.6 | 71.7 ± 8.0 | 73.4 ± 8.5 |
Sex (M: F) | 142:29 | 57:17 | 199:46 |
Therapy before HBT | |||
anticoagulants | 91 | 43 | 134 |
antiplatelets | 80 | 31 | 111 |
Antithrobmotic | |||
Single | 80 | 32 | 112 |
Multiple | 91 | 42 | 133 |
Condition requiring antithrobmotic | |||
Atrial fibrillation | 46 | 22 | 68 |
Ischemic heart disease | 53 | 33 | 86 |
Deep vein thrombosis | 7 | 1 | 8 |
Valve replacement | 9 | 8 | 17 |
Arteriosclerosis obliterans | 5 | 4 | 9 |
Cerebrovascular disease | 46 | 18 | 64 |
Type of heparin used | |||
Unfractionated heparin | 171 | 68 | 239 |
LMWH | 0 | 6 | 6 |